EUVIMEDEUVIMED entdecken
Leserbrief

Remission of refractory lupus nephritis is temporally associated with antitumour therapy, including durvalumab for endometrial carcinoma

Kuniyuki Aso, Koyo Matsuzaki, Jyunnosuke Saito, Masato Tarumi, Toshio Fujimoto, Tetsuya Horita

Annals of the Rheumatic Diseases · 2026-11 · 85 (11) · e115-e116

DOI: 10.1016/j.ard.2026.06.010 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Annals of the Rheumatic Diseases, 2026-11. Verfasst von Kuniyuki Aso und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Clinical Immunology, Sapporo Medical University School of Medicine, Sapporo, Japan; Department of Internal Medicine, T…. Die Arbeit nennt 6 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Rheumatology and Clinical Immunology, Sapporo Medical University School of Medicine, Sapporo, Japan; Department of Internal Medicine, Tomakomai City Hospital, Tomakomai, Japan. Electronic address: k.aso021…
  • Department of Internal Medicine, Tomakomai City Hospital, Tomakomai, Japan.
  • Department of Obstetrics and Gynecology, Tomakomai City Hospital, Tomakomai, Japan.

Zitieren

APA

Aso, K., Matsuzaki, K., Saito, J., Tarumi, M., Fujimoto, T., & Horita, T. (2026). Remission of refractory lupus nephritis is temporally associated with antitumour therapy, including durvalumab for endometrial carcinoma. Annals of the Rheumatic Diseases, 85(11), e115-e116. https://doi.org/10.1016/j.ard.2026.06.010

Vancouver

Aso K, Matsuzaki K, Saito J, Tarumi M, Fujimoto T, Horita T. Remission of refractory lupus nephritis is temporally associated with antitumour therapy, including durvalumab for endometrial carcinoma. Annals of the Rheumatic Diseases. 2026;85(11):e115-e116. doi:10.1016/j.ard.2026.06.010

BibTeX
@article{Aso2026,
  author = {Aso, Kuniyuki and Matsuzaki, Koyo and Saito, Jyunnosuke and Tarumi, Masato and Fujimoto, Toshio and Horita, Tetsuya},
  title = {Remission of refractory lupus nephritis is temporally associated with antitumour therapy, including durvalumab for endometrial carcinoma},
  journal = {Annals of the Rheumatic Diseases},
  year = {2026},
  volume = {85},
  number = {11},
  pages = {e115--e116},
  doi = {10.1016/j.ard.2026.06.010}
}
Kostenlos starten →